Tranq (Xylazine + Fentanyl) in Pennsylvania: What Families Need to Know
What Is Tranq Dope and Why Is It So Dangerous?
If you have a loved one struggling with opioid use in Pennsylvania, you may have heard the word “tranq” and not known what it meant. Tranq, also called tranq dope, is street slang for fentanyl that has been mixed with xylazine, a powerful sedative used in veterinary medicine. It is not approved for use in humans, and its presence in Pennsylvania’s drug supply has made an already devastating opioid crisis significantly more dangerous.
Xylazine is an alpha-2 adrenergic agonist, meaning it works on the central nervous system to slow brain activity, heart rate, and breathing. When combined with fentanyl, which already suppresses the respiratory system on its own, the two substances together can bring breathing to a complete stop. The sedation produced by tranq dope is extreme, and overdoses are harder to recognize and harder to reverse than a standard opioid overdose.
Pennsylvania, and Philadelphia in particular, has been at the center of the tranq crisis in the United States. Understanding what this drug is, how it affects the body, and what families can do is a critical first step toward protecting the people they love.
How Xylazine Spread Through Pennsylvania’s Drug Supply
Xylazine did not appear overnight. It has been present in Philadelphia’s illicit drug supply since at least 2019, when it was detected in nearly a third of overdose deaths involving fentanyl in the city. Over the following years, its presence grew dramatically. Drug suppliers began cutting fentanyl with xylazine because it is cheap, widely available through agricultural supply chains, and intensifies the sedative effects of fentanyl, which means a smaller amount of the drug goes further.
By early 2024, xylazine was detected in virtually all fentanyl samples tested in Philadelphia. The drug had spread well beyond the city, with Pennsylvania counties across the northeastern part of the state reporting some of the highest rates of xylazine-related EMS encounters in the entire country.
In response to the growing crisis, Pennsylvania classified xylazine as a Schedule III controlled substance in 2023, with Governor Josh Shapiro making that classification permanent in May 2024. The action was meaningful, but it also had an unintended consequence: suppliers began replacing xylazine with a newer and even less understood sedative called medetomidine. By late 2024, medetomidine had become the dominant adulterant in Philadelphia’s fentanyl supply, present in roughly 87 percent of samples tested. This shift in the drug supply is still unfolding, and families should understand that the risks associated with tranq dope are not disappearing. They are evolving.
The Signs of a Tranq Overdose and Why Naloxone Is Not Enough
One of the most important things families need to understand about tranq dope is how it changes the overdose picture. For years, Pennsylvania communities have been educated about naloxone, the opioid reversal medication sold under the brand name Narcan. Naloxone works by blocking opioid receptors in the brain and rapidly reversing the respiratory depression caused by drugs like fentanyl and heroin. It has saved countless lives.
But xylazine is not an opioid. Because it works on a different receptor system entirely, naloxone cannot reverse xylazine’s effects. A person overdosing on tranq dope may appear to resume breathing after receiving naloxone because the fentanyl component has been partially addressed, but they can remain deeply sedated and unresponsive due to the xylazine. This has led to confusion, delayed emergency response, and deaths that might otherwise have been prevented.
The signs of a tranq overdose include:
- Extreme sedation or unconsciousness that does not respond to naloxone
- Very slow or stopped breathing
- Blue or grayish skin, particularly around the lips and fingertips
- Dangerously low blood pressure
- Slowed heart rate
- Unresponsiveness even after multiple doses of naloxone
If you suspect someone is overdosing on tranq dope, experts still recommend administering naloxone immediately, because fentanyl is almost always present. You should also call 911 right away and begin rescue breathing if the person is not breathing on their own. Pennsylvania’s Good Samaritan Law protects people who call for help during an overdose from prosecution, so do not hesitate to call.
There is currently no FDA-approved reversal agent for xylazine. Treatment is supportive, meaning emergency responders focus on keeping the person breathing and stable until the drug clears their system.
The Wound Crisis: What Tranq Does to the Body Over Time
Beyond the immediate overdose risk, xylazine causes a separate and deeply alarming physical effect that has become one of its most recognizable signatures: severe skin wounds.
People who regularly use tranq dope, especially those who inject it, often develop open sores, ulcers, and areas of tissue death on their arms, legs, and other parts of the body. These wounds can appear even at injection sites far from where they develop, which suggests xylazine disrupts circulation and tissue health throughout the body, not just at the point of entry.
Without treatment, these wounds can become infected, spread rapidly, and in serious cases lead to the need for amputation. Medical centers across Pennsylvania, including the University of Pittsburgh Medical Center and Temple University health systems, have been developing protocols specifically for treating xylazine-associated wounds because they are unlike wounds clinicians typically see and require a specialized approach that combines wound care with addiction medicine and withdrawal management.
If your loved one has unexplained open sores or wounds that are not healing, especially on their arms or legs, this can be an important warning sign of xylazine use. These wounds require medical attention regardless of whether the person is currently seeking addiction treatment.
What Families Should Know About Withdrawal from Tranq Dope
Withdrawal from tranq dope is more complex than opioid withdrawal alone. Xylazine produces its own withdrawal syndrome, which can include severe anxiety, agitation, irritability, and dangerous spikes in blood pressure and heart rate. Standard opioid withdrawal medications do not fully address xylazine withdrawal, which means people attempting to detox from tranq dope require medically supervised care.
The situation has become even more complicated as medetomidine has replaced xylazine in parts of Pennsylvania’s drug supply. A medetomidine withdrawal syndrome was identified in Philadelphia hospitals between September 2024 and January 2025, with patients experiencing severe autonomic dysfunction including extreme blood pressure swings and dangerously elevated heart rates. Many required intensive care, and a significant percentage needed to be intubated. This is not a drug withdrawal that can be managed at home.
If your loved one is dependent on tranq dope and wants to stop using, they need medical supervision during the withdrawal process. Attempting to detox alone is not safe. Please reach out to a treatment provider before stopping use.
How to Talk to a Loved One About Tranq Use in Pennsylvania
Approaching a conversation about drug use with someone you love is one of the hardest things a family member can do. It is especially difficult when the drug involved carries as much stigma and fear as tranq dope. Here are some things to keep in mind:
Come from a place of concern, not judgment. People using tranq dope are often not aware of what is in the drugs they are taking. Many people using fentanyl in Pennsylvania do not know their supply contains xylazine or medetomidine. Approaching the conversation with that understanding can change the tone from accusation to genuine concern.
Focus on the physical risks. Sometimes the concrete reality of what tranq dope does to the body, including the wounds, the overdose risk that naloxone cannot fully reverse, and the severity of withdrawal, can break through in ways that broader conversations about addiction do not.
Be prepared for resistance. Addiction affects the brain’s ability to make decisions and assess risk. Your loved one may minimize what is happening or push back against your concern. This is a symptom of the disease, not a personal rejection.
Know that help is available. Recovery from opioid use disorder, including dependence on tranq dope, is possible. Medication-assisted treatment with buprenorphine or methadone can be highly effective for the fentanyl component of addiction, and treatment programs are increasingly equipped to address the full complexity of polysubstance use.
Addiction Treatment for Opioid and Tranq Use Disorder in Pennsylvania
High Focus Centers in Pennsylvania offers outpatient behavioral health treatment for adults and adolescents dealing with substance use disorders, including opioid addiction. Our Partial Hospitalization Programs (PHP) and Intensive Outpatient Programs (IOP) provide structured, evidence-based care that fits around real life. You do not have to enter a residential facility to get effective treatment.
We understand that the drug supply in Pennsylvania has changed and that families are navigating something that feels unprecedented. Our clinical team stays current on emerging substances and treatment approaches so that the people we serve receive care that reflects the reality of what they are facing.
If your loved one is struggling with fentanyl, tranq dope, or any form of opioid use disorder, we are here to help. Reaching out is the most important step
